Evaluation of Mirasol pathogen reduction system by artificially contaminating platelet concentrates with Staphylococcus epidermidis: A pilot study from India. - Wikidata - awgldk - TriplyDB

Evaluation of Mirasol pathogen reduction system by artificially contaminating platelet concentrates with Staphylococcus epidermidis: A pilot study from India.

Evaluation of Mirasol pathogen reduction system by artificially contaminating platelet concentrates with Staphylococcus epidermidis: A pilot study from India.

http://www.wikidata.org/entity/Q37193720

about

Towards pathogen inactivation of red blood cells and whole blood targeting viral DNA/RNA: design, technologies, and future prospects for developing countries Mirasol pathogen reduction technology treatment of human whole blood does not induce acute lung injury in mice.

P2860

Q29994506-A7C3337B-64C5-40E7-B4BE-153D3221661A Q33751938-013B28DC-18C9-499D-B959-DE28412AF97F

P2860

Evaluation of Mirasol pathogen reduction system by artificially contaminating platelet concentrates with Staphylococcus epidermidis: A pilot study from India.

http://www.wikidata.org/entity/Q37193720

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on July 2016

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Evaluation of Mirasol pathogen ...... dis: A pilot study from India.

@en

Evaluation of Mirasol pathogen ...... dis: A pilot study from India.

@nl

type

label

Evaluation of Mirasol pathogen ...... dis: A pilot study from India.

@en

Evaluation of Mirasol pathogen ...... dis: A pilot study from India.

@nl

prefLabel

Evaluation of Mirasol pathogen ...... dis: A pilot study from India.

@en

Evaluation of Mirasol pathogen ...... dis: A pilot study from India.

@nl

P1433

Q37193720-1F95AFE1-EE0F-490E-8FE8-EB5E989F2297

P1476

Q37193720-D80D48FA-50F0-4751-90A0-7CF6A775EF11

P2093

Q37193720-319B925D-D1B2-4D2A-9F06-3F1DCADB69C3

Q37193720-31E7E37B-BF5B-4A27-B989-0DC6843F9FED

Q37193720-323FCDE8-9020-47F8-934B-F34A13C9806F

Q37193720-436F2B36-898C-4927-BEF6-24293061ED80

Q37193720-463174D7-5869-44E5-9226-301133653149

Q37193720-4E3E331C-6028-42E0-B76C-6498DEF9F798

Q37193720-78F7274B-ACDC-4D6D-A39C-05F45E2C00D8

Q37193720-8554E7F5-91E8-4C7A-8D35-3F3BACC07953

Q37193720-AC0DF94D-4BCC-4154-AE1B-973F97E85A87

Q37193720-B7AC04CD-11CB-4788-A64A-C5645C610AAE

P2860

Q37193720-10D26BAA-0EAF-4CC2-BC4F-FDD11FE4806A

Q37193720-2490C944-9D9C-4090-8E14-80781CC5B6A2

Q37193720-28601C16-B6E4-4B2A-B107-D020DFEF5AE0

Q37193720-629C5CBB-6E0A-4678-A057-C00D0CD639B0

Q37193720-6ACD7AD5-50AF-4297-BF18-19A5351C0C6A

Q37193720-6EA539CC-32AD-479E-837F-4684A1BCFA39

Q37193720-756D5DCF-D4B9-41CA-830C-8B7E27120598

Q37193720-7E23E298-9E67-439C-8DFF-AF48AD5D4246

Q37193720-8E044D58-C293-46F9-95CE-CEFE2213E924

Q37193720-8F34CDD4-A9E0-46CF-A97D-1DF780C4EBAE

P304

Q37193720-E6693B70-5438-4D2C-AAAC-050AC8148E72

P31

Q37193720-8979DF50-9B41-4CA9-9F7B-19ECF85564B0

P356

Q37193720-00DBA4A1-3420-4DA5-A74C-C692C7377D0D

P433

Q37193720-C2C25EFD-A813-466D-B3AA-0F56A54080C2

P478

Q37193720-4659851D-3B9B-48FF-B12B-A863382A7F13

P50

Q37193720-164722F9-F074-415C-9F46-3958D184114A

P577

Q37193720-4D185E1A-11A4-401A-8E39-FE47BE324937

P698

Q37193720-D59E6559-8593-4706-AC03-619269ED9DBF

P921

Q37193720-CDE4FF52-7169-4CDA-A0A8-70A52041DF14

P932

Q37193720-CFBACAE4-AB86-4CB6-85C5-55359D38BB6B

P356

0973-6247.187946

P1433

Asian Journal of Transfusion Science

P1476

Evaluation of Mirasol pathogen ...... dis: A pilot study from India.

@en

P2093

Akanksha Bisht

http://www.w3.org/2001/XMLSchema#string

Diptiranjan Rout

http://www.w3.org/2001/XMLSchema#string

Kabita Chatterjee

http://www.w3.org/2001/XMLSchema#string

Kallol Saha

http://www.w3.org/2001/XMLSchema#string

Nitin Agarwal

http://www.w3.org/2001/XMLSchema#string

Rahul Chaurasia

http://www.w3.org/2001/XMLSchema#string

Shalini Tewari

http://www.w3.org/2001/XMLSchema#string

Shamsuz Zaman

http://www.w3.org/2001/XMLSchema#string

Shawn D Keil

http://www.w3.org/2001/XMLSchema#string

Surinder Singh

http://www.w3.org/2001/XMLSchema#string

P2860

Bacterial contamination of blood components.

Transfusion-Transmitted Bacterial Infections - Haemovigilance Data of German Blood Establishments (1997-2010).

Incidence and significance of the bacterial contamination of blood components.

Photochemical inactivation of selected viruses and bacteria in platelet concentrates using riboflavin and light.

Separation, identification and quantification of riboflavin and its photoproducts in blood products using high-performance liquid chromatography with fluorescence detection: a method to support pathogen reduction technology.

The Mirasol PRT system for pathogen reduction of platelets and plasma: an overview of current status and future trends.

Bacterial contamination and transfusion safety: experience in the United States.

Bacterial contamination of blood components: risks, strategies, and regulation: joint ASH and AABB educational session in transfusion medicine.

Update on the use of pathogen-reduced human plasma and platelet concentrates.

Transfusion-associated bacterial sepsis.

P304

127-131

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.4103/0973-6247.187946

http://www.w3.org/2001/XMLSchema#string

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

10

http://www.w3.org/2001/XMLSchema#string

P50

P577

2016-07-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27605849

http://www.w3.org/2001/XMLSchema#string

P921

P932

4993081

http://www.w3.org/2001/XMLSchema#string